This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Mercer Launches Health Care Reform Content Portal To Provide Latest News, Research, And Commentary On Implications For Employers, Employees

Stocks in this article: MMC

Mercer, a subsidiary of Marsh & McLennan Companies, today launched Mercer/Signal: US Health Care Reform, a new content portal that offers a steady stream of information and insight on the rapidly transforming health care environment and what these changes mean to employers and employees.

In addition to sharing Mercer’s own research and observations, Mercer/Signal: US Health Care Reform will draw content from a wide range of other credible sources, with commentary added by Mercer’s experts. Content will be updated daily. Visitors are asked to register, but there is no charge.

Tracy Watts, Mercer’s US Health Care Reform Leader, and Beth Umland, Director of Research for Employee Health & Benefits at Mercer, are leading the new content portal, supported by a team of Mercer subject matter experts representing all facets of health reform and health benefits. “Many employers find it difficult to wade through the torrent of information on health care reform and determine what’s relevant to their organization,” said Ms. Watts. “We created this new content portal as a one-stop source to help employers and others stay up to date, with news and insights delivered through articles, infographics, podcasts, videos, research, and more.”

Mercer/Signal: US Health Care Reform will cover a range of practical, regulatory, and legislative topics related to health reform, including the development of private exchanges such as Mercer Marketplace, the public exchanges, voluntary benefits, and retiree medical coverage.

“The Affordable Care Act has produced the most significant changes to the US health care system since Medicare was established in 1965,” said Bernie Walsh, leader of Mercer’s US Health & Benefits Business. “Through Mercer/Signal: US Health Care Reform, we aim to strengthen our position as a valued partner in helping employers address the challenges they face around both health reform and broader health benefit issues.”

Employers, journalists, and others may sign up for the Mercer/Signal: US Health Care Reform content portal at http://ushealthnews.mercer.com. Subscribers will gain access to all content, be able to comment and engage in conversations, and receive a weekly email announcing new content. Content from the portal also will be shared through LinkedIn and on Twitter @MercerUSHealth.

About Mercer

Mercer is a global leader in talent, health, retirement, and investments. Mercer helps clients around the world advance the health, wealth, and performance of their most vital asset – their people. Mercer’s more than 20,000 employees are based in 42 countries and the firm operates in more than 120 countries. Mercer is a wholly owned subsidiary of Marsh & McLennan Companies (NYSE: MMC), a global team of professional services companies offering clients advice and solutions in the areas of risk, strategy, and human capital. With over 55,000 employees worldwide and annual revenue exceeding $12 billion, Marsh & McLennan Companies is also the parent company of Marsh, a global leader in insurance broking and risk management; Guy Carpenter, a global leader in providing risk and reinsurance intermediary services; and Oliver Wyman, a global leader in management consulting. For more information, visit www.mercer.com. Follow Mercer on Twitter @MercerInsights.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs